Meromust 500mg Injection contains Meropenem, a broad-spectrum carbapenem antibiotic effective against a wide range of Gram-positive and Gram-negative bacteria, including multidrug-resistant strains. It is indicated for the treatment of severe bacterial infections such as complicated intra-abdominal infections, bacterial meningitis, complicated skin and soft tissue infections, and febrile neutropenia. Meropenem exerts its bactericidal action by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins, leading to cell lysis and death. Administered intravenously, Meromust 500mg Injection ensures rapid and effective systemic distribution, making it suitable for critically ill patients requiring immediate antimicrobial therapy. The dosage and duration of treatment should be individualized based on the severity of infection, renal function, and clinical response. Common adverse effects include gastrointestinal disturbances, headache, rash, and potential hypersensitivity reactions. Caution is advised in patients with a history of beta-lactam allergy. Renal function monitoring is recommended during prolonged therapy to adjust dosing accordingly. Meromust 500mg Injection should be used under strict medical supervision to prevent the development of antibiotic resistance and to ensure optimal therapeutic outcomes. It is contraindicated in patients with known hypersensitivity to Meropenem or other carbapenems.